Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors

IL1R2 Inhibition: A New Strategy to Boost Cancer Immunity

Triple-negative breast cancer (TNBC) remains a therapeutic challenge due to its aggressive nature and resistance to standard treatments

Is AI The New Radiologist For Breast MRI?

This article explores the burgeoning role of artificial intelligence (AI) in breast MRI, a crucial diagnostic tool.

Amivantamab Plus Chemotherapy Outperforms Standard Care in Post-Osimertinib NSCLC

Non-small cell lung cancer (NSCLC) harboring EGFR mutations presents a significant therapeutic challenge.

Breast Cancer Secrets: AI-Powered Precision Medicine

This article delves into a groundbreaking study that utilized a comprehensive single-cell breast tumor atlas to unravel the complexities of tumor

Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions

Summary of

Understanding Sepsis and Precision-Medicine-Based Immunotherapy: A Pathophysiological Perspective

Summary of "The pathophysiology of sepsis and precision-medicine-based immunotherapy" by Giamarellos-Bourboulis EJ, Aschenbrenner AC, Bauer M, et al.

Unveiling Tumor Immunity: Pan-Cancer Proteogenomics Characterization

Summary of "Pan-cancer proteogenomics characterization of tumor immunity" by Petralia F, Ma W, Yaron TM, et al.

Revolutionizing Cancer Treatment: ESMO's Updated Recommendations for Tumour NGS

Summary of ESMO's Updated Recommendations for Tumour NGS

How Cancer Cells Evade Immune Destruction and the Fight Back

This review explores the intricate link between immune evasion strategies employed by cancer cells and their resistance to cell death pathways.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

Cancer remains a complex puzzle, and understanding the role of immune cells within the tumor microenvironment is crucial.

Sound Waves and Self-Destruction: A Promising Nanotech Weapon in the Fight Against Cancer

Traditional cancer treatments often struggle to overcome the body's own immune suppression mechanisms.

IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System

This review focuses on a promising new target: IGSF8 (immunoglobulin superfamily member 8).